Caravelle acquires an equity stake in Naturex

Caravelle acquires an equity stake in Naturex

Caravelle's equity investment follows the sale by Natraceutical of its stake that represented 15.35 percent of the share capital and 8.27 percent of the voting rights.

Naturex, the global leader in speciality plant-based natural ingredients, announces an equity investment by Groupe Caravelle, a diversified French industrial group with holdings in the pharmaceutical, industrial bodywork, mechanics and hotel sectors.

Natraceutical sells its equity stake
Caravelle's equity investment follows the sale by Natraceutical of its stake that represented 15.35 percent of the share capital and 8.27 percent of the voting rights on Dec. 5, 2012.

Natraceutical, the Spanish group, had become a shareholder in December 2009 with a 38 percent stake after the Naturex acquired its Ingredients Division. Through this latter acquisition Naturex doubled in size and achieved a leadership position in its market.

Natraceutical had indicated its intention since 2011 to gradually divest its holdings in Naturex’s share capital and in recent months has significantly reduced its stake.

Caravelle, a new partner
This friendly acquisition fits within the development strategy of Caravelle that has clearly demonstrated its wish to participate in pursuing the development projects of Naturex Group in line with latter's strategy over the last 20 years.

"We welcome Caravelle Group's addition as a shareholder and will propose that Ms. Hélène Martel-Massignac, Caravelle's CEO, be appointed as a new member of Naturex's Board of Directors,'' commented Naturex's Chairman and CEO Thierry Lambert. "This proposed nomination will be submitted to a vote at the next Shareholders Meeting."

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish